 |
|
The treatment paradigm of non-small cell lung cancer (NSCLC) has shifted in recent years. The inclusion of novel chemotherapeutic agents and targeted therapies into the multimodality approach has resulted in improved patient outcomes. However, the severity and duration of side effects associated with these agents can affect quality of life as well as efficacy of treatment. It is often necessary to adjust treatment schedules, sequences, doses, and number of cycles to alleviate adverse events. Oncology nurses and advanced practice oncology nurses play a critical role in ensuring the optimal delivery of these agents. During this interactive, educational roundtable discussion, a lung cancer oncology nurse key opinion leader will review current treatment options for NSCLC. Our expert faculty will discuss common treatment experiences, and effective nursing management strategies to ensure optimal patient outcomes. The remainder of the program will focus on case-based presentations highlighting the clinical course of patients with NSCLC who have been treated with a variety of therapeutic regimens. These case studies will allow the audience to explore the journey from diagnosis through treatment, including side-effect onset and resolution. The discussion will provide an explanation of the rationale behind the selection of each specific treatment approach for these patients. The goal is to assist oncology nurse attendees in their critical evaluation of individualized treatment planning based on a patient’s risk profile, disease presentation, and lifestyle. Following the case studies, each table of participants will collaborate to address a list of questions related to the management of the case, with one nurse from each table sharing the critical analysis. Faculty will provide expert feedback to these interactive sessions.
|